Skip to main content

A simple method to improve the antibiotic elution profiles from polymethylmethacrylate bone cement spacers by using rapid absorbable sutures



Antibiotic-loaded bone cement beads and spacers have been widely used for orthopaedic infection. Poor antibiotic elution is not capable of eradicating microbial pathogens and could lead to treatment failure. The elution profiles differ among different cement formulations. Although Simplex P cement has the least release amount, it is widely used due to its ready availability. Previous methods aiming to improve the elution profiles were not translated well to clinical practice. We sought to address this by using easily available materials to improve the elution profile of antibiotics from PMMA, which allows clinicians to implement the method intraoperatively.


Vancomycin was mixed with Simplex P cement. We used Vicryl Rapide sutures to fabricate sustained-release cement beads by repetitively passing the sutures through the beads and/or mixing suture segments into the cement formulation. Vancomycin elution was measured for 49 days. The mechanism of antibiotic release was observed with gross appearance and scanning electron microscopic images. The antimicrobial activities against MRSA were tested using an agar disk diffusion bioassay.


Passing Vicryl Rapide sutures through cement beads significantly improved the elution profiles in the 7-week period. The increased ratios were 9.0% on the first day and 118.0% from the 2nd day to the 49th day. Addition of suture segments did not increase release amount. The Vicryl Rapide sutures completely degraded at the periphery and partially degraded at the center. The antibiotic particles were released around the suture, while antibiotic particles kept densely entrapped in the control group. The antimicrobial activities were stronger in passing suture groups.


Passing fast absorbable sutures through PMMA cement is a feasible method to fabricate sustained-release antibiotic bone cement. Intra-cement tunnels can be formed, and the effect can last for at least 7 weeks. It is suitable for a temporary spacer between two stages of a revision surgery.

Peer Review reports


Antibiotic-loaded bone cement spacers and beads have been widely used for the treatment of orthopaedic infections, including prosthetic joint infection [1,2,3], infected non-union [4], and chronic osteomyelitis [5]. In two-stage surgeries, high-dose antibiotic-loaded polymethylmethacrylate (PMMA) cement beads or spacers are implanted after hardware removal and surgical debridement in the first stage. PMMA cement serves as a local antibiotic carrier to achieve local antibiotic concentrations that exceed the minimal inhibitory concentrations. PMMA is usually placed in position for 6–8 weeks before the final prosthesis, or internal fixators are implanted [3, 6]. Therefore, the elution profiles of antibiotics during this period are important. However, the total release percentage of commonly used antibiotics, such as vancomycin, cefazolin and gentamicin, is less than 10% [7,8,9]. The elution profiles differ among different cement formulations. Palacos cement and Copal cement have been shown to have the highest rates of elution or effectiveness in preventing biofilm formation, whereas Stryker Surgical Simplex P cement has the lowest rates [10, 11]. A previous clinical study showed that the in vivo vancomycin concentration released from Simplex P cement spacer became undetectable on the 7th day after implantation in 40% of patients [12]. However, not all types of cement are available to clinicians. Therefore, the development of practical methods to improve elution profiles is important.

Factors affecting antibiotic elution include antibiotic loading dose, physicochemical properties of antibiotics, mixing methods of antibiotics, cement porosity, and cement composition [13]. Various methods have been developed to improve antibiotic elution profiles, and the creation of high porosity has been a major concept in many studies [13,14,15,16,17,18,19,20,21,22,23]. The incorporation of particles made of various materials, such as gelatin [15], poly(lactic-co-glycolic) acid (PLGA) [22, 23], α-tricalcium phosphate [16], calcium sulphate [18] and antibiotic-loaded nano-sized liposomes [24] as poragens into PMMA cement is most commonly used. These particles can significantly increase the porosity and its interconnectivity of PMMA spacers, facilitating efficient antibiotic release [13]. Another strategy is the use of other biodegradable materials instead of PMMA as antibiotic carriers, such as calcium sulfate [25, 26], PLGA [13], and hydroxyapatite [27]. However, most of these methods are still in the experimental stage. Although there have been some commercialized products, such as Stimulan calcium sulfate beads [25, 26], they are not widely available worldwide. Furthermore, biodegradable carriers cannot serve as temporary spacers during two-stage revision arthroplasty. Therefore, there is a large gap between laboratory and clinical practices, and antibiotic-loaded PMMA cement remains the most popular method.

This study aimed to use easily available materials to improve the elution profile of antibiotics from PMMA, which allows clinicians to implement the method intraoperatively. We hypothesized that biodegradable sutures passing through PMMA could leave tunnels to facilitate antibiotic release after the sutures are hydrolyzed.


Fabrication of antibiotic-loaded PMMA

Having the less favorable antibiotic elution data, Stryker Surgical Simplex P [Stryker, Kalamazoo, MI] was the target PMMA product in this research. It is a commercial bone cement widely used worldwide. The chemical composition of Simplex P bone cement is shown in Table 1. The P/L ratio is 2.11. The viscosity of Simplex P at room temperature is classified as medium viscosity [28]. Vancomycin was chosen as the target antibiotic because of its common use in clinical practice and its activity against methicillin-resistant Staphylococcus aureus (MRSA), which is one of the most common pathogens causing osteomyelitis and implant-related infections [29, 30]. The Vicryl Rapide suture (Ethicon, USA) was chosen because of its fast absorption with total hydrolysis at 42 days, which is approximately 6–8 weeks between the two stages of revision arthroplasty. The Vicryl Rapide suture is composed of a copolymer made from 90% glycolide and 10% L-lactide.

Table 1 Chemical composition of Simplex P bone cement

We speculated that passing sutures through the bone cement and adding suture segments to the bone cement might improve antibiotic elution. Passing biodegradable sutures through PMMA ensures the exposure on PMMA surface at both ends of the suture. It may leave tunnels to facilitate antibiotic release after hydrolysis. Suture segments might act as poragens to create high porosity after hydrolysis of the segments. In previous studies, the addition of biodegradable particles as poragens effectively created a high porosity [15, 22, 23].

There was one control group (no suture) and three experimental groups: (1) passing suture group, (2) passing suture + segment group, and (3) segment group (Fig. 1). Briefly, 2 g of vancomycin powder (Sigma, USA) was added to 40 g of PMMA powder. For the “segment group” and the “passing suture + segment group”, 180 cm (two sachets) of 2 − 0 (0.3 mm in diameter) undyed Vicryl Rapide sutures were cut into 0.5 cm segments and mixed with the PMMA/vancomycin powder in this step. The sutures were 0.19 gm. The percentage of additive by weight was 0.48% for this modification. The mixed powders were hand-stirred for 2 min before the addition of methylmethacrylate (MMA) liquid. Spherical beads with a diameter of 20 mm were created using silicone molds. For the “passing suture group” and the “passing suture + segment group”, we passed 50 cm of Vicryl Rapide sutures repetitively through each bead during the dough phase. Beads without Vicryl Rapide sutures served as the control group. The temperatures of the cement beads were measured every 30 s until the temperature decreased below 50°C.

Fig. 1
figure 1

The experimental groups: (A) Passing suture group. (B) Passing suture + segment group. (C) Segment group. Light gray lines: sutures passed through cement beads. Dark gray segments: 0.5 cm suture segments

Antibiotic elution profile

Elution profile analysis was performed according to previous studies, with minor modifications [11]. Briefly, two beads were placed in a 50-mL flask with 15 mL of sterile phosphate-buffered saline (PBS), a volume sufficient to completely submerge both beads. Samples were stored at 37°C for 49 days, with PBS removed at 24-hour intervals for 10 days, at 3-day intervals for 12 days, at 5-day intervals for 20 days, and at 7-day intervals for the last 7 days. The vancomycin concentration of each sample was then measured by UV–vis spectroscopy using a SpectraMax Plus-384 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). [31]. The concentration was determined by measuring absorbance at 282 nm. The absorbance of monomers, glycolic acid, and lactic acid released after hydrolysis of Vicryl Rapide sutures was extremely low at 282 nm [32, 33]. The experiments were performed in triplicate.

In vitro cytotoxicity assay

We used a human osteosarcoma cell line, MG-63 (from European Collection of Authenticated Cell Culture, ECACC code: 86,051,601), to test the cell viability. Briefly, MG-63 cells were seeded to 96-well plates at a density of 1 × 104 cells/well. After incubation for 24 h, the cells were incubated in fresh media supplemented with 10% PMMA immersed PBS at 1st, 10th, 19th, 32nd and 49th days. After 24 h, the cells were placed in fresh medium containing 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT, Sigma, St. Louis, MO, USA) and incubated at 37 ◦C for 3 h. The absorbance was measured at 570 nm with UV–vis spectroscopy using a SpectraMax Plus-384 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). The cell viability in each group was calculated and expressed as a percentage relative to that of the control group.

Bioassay of antibiotic activity

The antimicrobial activity of bead-immersed PBS collected on the 1st, 10th, 19th, 32nd and 49th days was estimated using an agar disk diffusion bioassay. Briefly, 10-mm antibiotic discs were loaded with 30µL of the PBS samples. The discs were subsequently placed on Mueller-Hinton agar plates (Sigma, St. Louis, MO, USA) inoculated with methicillin-resistant Staphylococcus aureus at 37°C. The zone of inhibition (ZOI) was measured after 24 h to compare the antimicrobial activity between each group (Fig. 2).

Fig. 2
figure 2

 A. The presentative photo of agar disk diffusion bioassay (the result of the 1st-day sample for the passing suture group). B. The illustration of measurement of ZOI.

Gross appearance and microarchitecture of PMMA/sutures

After immersion in PBS, the PMMA beads were fractured using osteotomes. The gross appearance was observed to determine whether the sutures were completely hydrolyzed. The fracture surfaces were studied using a JSM-7600 F scanning electron microscope (SEM)(JEOL, Japan). An energy dispersive X-ray spectroscopy (EDS) was also used to visualize and analyze the surface features. The energy of the electron beam was 10 kV. To ensure high quality images, the samples were sputter-coated with platinum using a JFC 1600 auto-fine coater (JEOL, Japan).

Statistical analysis

All statistical analyses were performed using Real Statistics Resource Pack software (release 8.0) on a Microsoft Windows-based computer. The antibiotic release amounts in the four groups at each time point were compared using the Friedman test. Post-hoc analysis with the Nemenyi test was conducted to identify which pairwise groups had a significant difference. Statistical significance was set at a p < 0.05.


The polymerization temperature is shown in Fig. 3. The peak temperature was comparable between each group (P = 0.77). The curing time of the control group was 8 min 52 s ± 15 s. Compared with the control group, the mean curing time was 22 s shorter in the “passing suture group” (P = 0.007) and 20 s shorter in the “passing suture + segment group” (P = 0.006). The mean value of the cumulative antibiotic release from the three experimental groups and the control group is shown in Fig. 4. The amount released among the four groups was significantly different (P < 0.001 in the Friedman Test). The post-hoc analysis showed that the “passing suture group” and the “passing suture + segment group” released more antibiotics than the “segment group” and the control group (P < 0.001). The addition of suture segments did not increase the antibiotic release amount (P > 0.99 for the “passing suture group” vs. the “passing suture + segment group”, and P = 0.82 for the “segment group” vs. the control group). A burst release was observed in each group on the first day. Compared with the control group, the total release amount from the “passing suture group” increased by 39.9%. The increased ratios were 9.0% on the first day and 118.0% from the 2nd day to the 49th day.

Fig. 3
figure 3

The polymerization temperature of bone cement

Fig. 4
figure 4

The cumulative antibiotics from the PMMA cement. Passing rapid absorbable sutures increased the release amount

The cell viability of each group was shown in Fig. 5. Passing sutures and the addition of suture segments did not affect cell viability (P > 0.05 in the Friedman Test). The antimicrobial activities of the bead-immersed PBS were shown in Fig. 6. The ZOI of the 1st-day PBS-loaded disc was comparable between each group. The ZOI was larger in “passing suture group” and the “passing suture + segment group” for the 16th-day, 32nd-day and 49th-day PBS-loaded discs.

Fig. 5
figure 5

The results of cytotoxicity assay. The cell viability was comparable between each group

Fig. 6
figure 6

The results of bioassay of antibiotic activity. (A) The ZOI was larger in the “passing suture group” and “passing suture + segment group” (arrow in the left photo) for the 16th-day samples, whereas the ZOI was narrow in the control group and the “segment group” (arrow in the right photo). (B) The ZOI was invisible in the control group and the “segment group” (right photo), whereas there was still a narrow ZOI in the “passing suture group” and “passing suture + segment group” (arrowhead in the left photo) for the 32nd and 49th-day samples. (C) The ZOI was comparable between each group for 1st-day samples and significantly different for 16th-day, 32nd-day and 49th-day samples. * P < 0.05 compared to the control group

Regarding gross appearance, the sutures in the most peripheral area were completely hydrolyzed (Fig. 7 A), whereas the sutures near the center of the beads were partially hydrolyzed. The sutures became much thinner and fragile, leaving an obviously visible tunnel space around them (Fig. 7B). Analysis of the SEM images showed that the sutures were almost completely hydrolyzed in the outer half of the beads (Fig. 8). Antibiotic particles around the suture tunnel were absent, and their nest holes were left empty. The nest holes were the spaces previously embedded with antibiotic particles. In contrast to the round pores in the PMMA cement, their shape was irregular and consistent with that of the antibiotic particles in Fig. 9. In accordance with the gross appearance, the sutures at the bead center were partially hydrolyzed. The peripheral filaments degraded to segments that were much shorter than the core filaments (Fig. 10). These results indicate that the degradation began from the periphery of the multifilament sutures, and the tunnel space appeared and gradually enlarged. In the control group, numerous antibiotic particles were still densely entrapped in the outer half and center of the cement beads (Fig. 9).

Fig. 7
figure 7

The gross appearance of the cement bead after PBS immersion. (A) The sutures at the most peripheral area were completely hydrolyzed (arrowhead). (B) The sutures at the fracture surface near the bead center were partially hydrolyzed, and visible tunnel space appeared around the suture. (arrow)

Fig. 8
figure 8

SEM image of the suture passed cement beads (outer half) after PBS immersion. (A) Sutures were almost completely hydrolyzed at the outer half of the bead. Arrow: the remaining suture. Arrowheads: empty nest holes after antibiotics were released. (B) High magnification image (1000x). Arrow: the tunnel space. Arrowheads: empty nest holes after antibiotics were released

Fig. 9
figure 9

SEM image of the cement beads without suture (control group). Arrowheads: densely entrapped antibiotic particles

Fig. 10
figure 10

SEM image of the suture passed cement beads (near the bead center) after PBS immersion. (A) Sutures were partially hydrolyzed near the bead center. (B) High magnification image (250x). Arrow: the peripheral filaments degraded to much shorter segments. Arrowheads: the core filaments


The most important contribution of this study is that we successfully improved the vancomycin elution profile by simply passing fast absorbable sutures through antibiotic-loaded PMMA. Because the Vicryl Rapide suture is a commonly used commercialized product [34, 35], its safety has been well established. Furthermore, orthopaedic surgeons are familiar with the skills required to pass sutures through PMMA beads or spacers in the dough phase. Therefore, this method is feasible and easily operable in the clinical practice.

Antibiotic release from PMMA cement has been previously reported. The Simplex P cement has the lowest release amount among various formulations. However, it is widely used to fabricate cement spacers owing to its availability [12, 36]. In consistent with previous in vitro studies [7], the present results showed that the cumulative vancomycin release from plain Simplex P cement was less than 3%. In vivo vancomycin concentration using Simplex P cement spacers could become undetectable in the early period [12], which may be a cause of treatment failure [36]. Therefore, improving the elution profile of antibiotics is important in clinical practice. Regardless of the cement formulation, there is always a burst of antibiotic release on the first day [31]. The release amount subsequently drops rapidly to an extremely low level, and most of the antibiotics remain entrapped inside the PMMA cement. Although various methods have been developed to facilitate antibiotic release, many would increase the burst amount on the first day [13, 15]. The burst release of antibiotics can cause transient high serum antibiotic concentrations, resulting in acute kidney injury [37,38,39]. In contrast, the current method only increased a small amount of vancomycin (9%) on the first day, whereas there was a more than two-fold increase in the release amount in the following 7 weeks. Since cement spacers or beads are usually retained in position for 6–8 weeks in two-stage revision surgeries [3, 6], the release in the late period is important to ensure successful eradication of the pathogen. In the current study, the absorption of biodegradable sutures began from the periphery to the center of the spherical beads. The antibiotic particles observed with SEM were absent around the absorbed sutures, whereas numerous particles were still densely entrapped in the control group. Therefore, it could be speculated that the antibiotics were released after the tunnel space appeared. In addition to passing sutures through bone cement, we also mixed 0.5 cm suture segments into the PMMA powder to simulate previous methods [15, 17, 22]. However, the addition of suture segments did not result in improved elution profiles. The possible reason was that the number of segments may be insufficient because there were only 360 suture segments in 40 g of PMMA. Insufficient segments might result in decreased suture exposure on the bead surface and poor connection between suture segments. Because PMMA is highly hydrophobic, decreased suture exposure and poor inter-segment connection would prevent hydrolysis of the suture segments trapped inside the bone cement. Therefore, these segments could not act as poragens well. A previous study using gelatin particles as poragens showed that a higher number of particles results in higher porosity [15]. These suture segments were cut from two sachets of Vicryl Rapide sutures. It would be less cost-effective to have enough segments cut from more sachets of sutures. Since this study aimed to develop a practical method, we did not add more segments.

Regarding the sustained release of antibiotics from PMMA, promising results have been reported in previous studies [13,14,15,16,17,18, 21, 22, 24, 40, 41]. One major concept of many studies was the creation of high porosity and interconnectivity of the bone cement [13, 15,16,17,18, 21, 22, 24, 40]. For example, the addition of 200–400 μm gelatin particles as poragens could increase porosity, resulting in an increase in the amount and rate of drug release. It also made the mechanical properties of PMMA cement more comparable to those of cancellous bone [15]. Moreover, the incorporation of many other degradable materials, such as α-tricalcium phosphate [16], calcium phosphate [18] and PLGA [23, 42] has yielded good results. Previous reports have shown that the controlled and gradual release of antibiotics after the addition of poragens can last for a long period ranging from 4 to 8 weeks [13, 18]. Recently, nanotechnology-based carriers have been developed to improve the release kinetics of antibiotics from PMMA [43, 44]. These nano-carriers include liposomes [24], mesoporous silica [45, 46], hydroxyapatite nano-rods [47], magnetic nanoparticles [48], titanium dioxide (TiO2) nanotubes [49,50,51], carbon nanotubes [52] and clay nanotubes [53]. The addition of nanoparticles could provide larger surface area, increase local antibiotic concentration, and exert synergistic antibiotic effect by carrying multiple antibiotics [47]. For example, the total release of vancomycin from TiO2 nanotubes functionalized Simplex-P bone cements could be more than 50% of the total amount. The extended release of vancomycin could last for at least 80 days. Besides, the mechanical properties were well preserved after incorporation of the TiO2 nanotubes [49]. Similarly, the nano-sized liposomal drug delivery system for PMMA bone cement increased release of gentamicin from less than 10% to more than 20% of total antibiotics in 60 days [24]. In addition to the concept of sustained antibiotic release, a refillable antibiotic system composed of insoluble cyclodextrin (CD) microparticles and PMMA has been developed [41, 54, 55]. This delivery system not only allows consistent release of antibiotics but also enables antibiotic refilling through affinity-based interactions. The duration of the consistent release could be more than 60 days and the refilling capacity could provide an additional period of antimicrobial activity for about 30 days [54], which allows complete eradication of pathogenic bacteria.

Apart from the incorporation of the above materials, another strategy is to change the composition of the PMMA cement [14]. A reduction in the L/P ratio and an increase in the radiopacifier ratio can lead to increased porosity, pore diameter and antibiotic elution. The cumulative antibiotic release from PMMA at 70% L/P ratio was more than 70% of the total antibiotics, while PMMA at 100% L/P ratio released less than 20% of antibiotics [14]. However, the burst release from PMMA at 70% L/P ratio within the first day was also five times greater than that from PMMA at 100% L/P ratio, which could lead to antibiotic toxicities. Aeration is another possible method for creating a high porosity [20]. A prolonged aeration time could improve the open-pore structure and increase the average pore size. Although antimicrobial activity has been tested to prove its effectiveness, the released antibiotics have not been quantified. Further studies are required to determine the optimal amount and rate of release using aeration. Recently, various biodegradable antibiotic carriers have been fabricated using calcium phosphates, calcium sulfate hemihydrate, bioactive glass, synthetic polymers and composites [19, 26, 56,57,58,59,60]. The strengths of these biodegradable carriers include better osteogenesis, sufficient antibiotic release and no need of surgical removal. A well-designed biodegradable carrier can provide a sufficient antibiotic concentration in the bone for at least 7 weeks, which can eradicate bacteria in animal models of chronic osteomyelitis [19]. Nevertheless, these carriers cannot serve as appropriate spacers because of their biodegradable nature. Bone cement made of other undegradable materials, such as silorane-based biomaterial [61], may be a solution. Silorane-based cements were initially developed for the use in dentistry. Compared to the PMMA cement, the silorane-based bone cement could release more rifampin and vancomycin within two weeks. Furthermore, the mechanical properties of silorane-based bone cement were not affected by the addition of antibiotics. However, to the best of our knowledge, most of these experimental results have not been translated well into clinical use. The causes of this phenomenon are multifactorial, including unproven safety, high costs, and the complex commercialization process of a new product. Therefore, antibiotic-loaded PMMA spacers without the addition of any other materials remains the most commonly used method. Compared to the results of above studies, the increase amount of vancomycin by using rapidly absorbable sutures was much less. We speculate that the surface area created by the suture tunnels was much smaller than that created by the poragens in previous studies. However, the materials in the present study are easily available to orthopaedic surgeons. Therefore, this method appears to be a transitional solution for improving the elution of antibiotics.

Because the addition of other materials may disturb the polymerization reaction and increase the release of the toxic MMA monomer, cytocompatibility test is essential to determine the safety. There are various methods, such as MTT assay, lactate dehydrogenase assay and cell counting kit-8 assay, to test the cytotoxicity. In previous studies, MTT cellular viability assay has been the most common method to test the cytotoxicity of bone cements [18, 19, 48, 52]. The cell viability was not affected by the addition of magnetic nanoparticles [48], carbon nanotubes [52], calcium phosphate [18], and gelatin [15] into PMMA. In the present study, the cell viability did not decrease after the incorporation of Vicryl Rapide sutures. Therefore, this is a safe method to improve the antibiotic elution from PMMA cement spacers.

This study has several limitations. First, we could only confirm the elution profile of vancomycin. Clinicians can use different antibiotics. Vancomycin is one of the most common antibiotics used in cement spacers. Further studies are necessary to determine the effects of other antibiotics. Second, to simulate the general condition, we used an intermediate size of spherical cement beads between the larger cement spacers and smaller beads. It remains unclear whether different sizes or shapes would have different effects. Nevertheless, the rapid absorbable sutures are supposed to degrade in a similar way, which could facilitate antibiotic release as well. Finally, we did not test the mechanical properties of the PMMA cement. Bone cement with mechanical properties close to those of the surrounding cancellous bone may improve prosthesis longevity [15]. Because passing sutures is not possible for definite fixation of the final prosthesis, this method is suitable for temporary spacers between the two stages of a revision surgery only. Because the spacers are removed in the second stage, their mechanical strength appears to be of minimal importance.

In conclusion, passing fast absorbable sutures repetitively through PMMA cement is a feasible method to fabricate sustained-release antibiotic-loaded bone cement. Intra-cement tunnels can be formed after suture degradation. The effect can last for at least 7 weeks, which is suitable for a temporary spacer between the two stages of a revision surgery.

Data Availability

The data and material in this research have been all described in the article.



energy dispersive X-ray spectroscopy




methicillin-resistant Staphylococcus aureus


phosphate buffered saline


poly(lactic-co-glycolic) acid




scanning electron microscope


zone of inhibition (ZOI)


  1. Kildow BJ, et al., Long Term Results of Two-Stage Revision for Chronic Periprosthetic Knee Infection: A Multicenter Study. J Arthroplasty, 2022.

  2. Hulsman L, et al., Time Required for Planned and Unplanned Episodes of Care in Septic Two-Stage Revision Hip and Knee Arthroplasty. J Arthroplasty, 2022.

  3. Kildow BJ, Della-Valle CJ, Springer BD. Single vs 2-Stage Revision for the Treatment of Periprosthetic Joint Infection. J Arthroplasty. 2020;35(3s):S24-s30.

    PubMed  Google Scholar 

  4. Jain AK, Sinha S. Infected nonunion of the long bones. Clin Orthop Relat Res, 2005(431): p. 57–65.

  5. McKee MD, et al. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthop Trauma. 2010;24(8):483–90.

    Article  PubMed  Google Scholar 

  6. Bernard L, et al. Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect. 2010;61(2):125–32.

    Article  PubMed  Google Scholar 

  7. Martínez-Moreno J, et al. Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement. Orthop Surg. 2017;9(4):331–41.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lee SH, et al. Elution and Mechanical Strength of Vancomycin-Loaded Bone Cement: In Vitro Study of the Influence of Brand Combination. PLoS ONE. 2016;11(11):e0166545.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Parra-Ruíz FJ, et al. Development of advanced biantibiotic loaded bone cement spacers for arthroplasty associated infections. Int J Pharm. 2017;522(1–2):11–20.

    Article  PubMed  Google Scholar 

  10. Fink B, et al. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011;469(11):3141–7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Meeker DG, et al. Comparative Study of Antibiotic Elution Profiles From Alternative Formulations of Polymethylmethacrylate Bone Cement. J Arthroplasty. 2019;34(7):1458–61.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hsu YH, et al. Vancomycin and Ceftazidime in Bone Cement as a Potentially Effective Treatment for Knee Periprosthetic Joint Infection. J Bone Joint Surg Am. 2017;99(3):223–31.

    Article  PubMed  Google Scholar 

  13. Wall V, et al., Controlling Antibiotic Release from Polymethylmethacrylate Bone Cement. Biomedicines, 2021. 9(1).

  14. Chen IC, et al., Influence of Antibiotic-Loaded Acrylic Bone Cement Composition on Drug Release Behavior and Mechanism. Polymers (Basel), 2021. 13(14).

  15. Chen L, et al. Fabrication of the antibiotic-releasing gelatin/PMMA bone cement. Colloids Surf B Biointerfaces. 2019;183:110448.

    Article  CAS  PubMed  Google Scholar 

  16. Fini M, et al. A bone substitute composed of polymethylmethacrylate and alpha-tricalcium phosphate: results in terms of osteoblast function and bone tissue formation. Biomaterials. 2002;23(23):4523–31.

    Article  CAS  PubMed  Google Scholar 

  17. Khandaker M, Meng Z. The Effect of Nanoparticles and Alternative Monomer on the Exothermic Temperature of PMMA Bone Cement. Procedia Eng. 2015;105:946–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Matos AC, et al. Novel doped calcium phosphate-PMMA bone cement composites as levofloxacin delivery systems. Int J Pharm. 2015;490(1–2):200–8.

    Article  CAS  PubMed  Google Scholar 

  19. Mistry S, et al. Biological analysis of an innovative biodegradable antibiotic eluting bioactive glass/gypsum composite bone cement for treating experimental chronic MRSA osteomyelitis. J Pharm Anal. 2022;12(1):164–77.

    Article  PubMed  Google Scholar 

  20. Pałubicka A, Czubek J, Wekwejt M. Effect of aeration of antibiotic-loaded bone cement on its properties and bactericidal effectiveness. 70: Minerva Ortopedica e Traumatologica; 2019.

  21. Sa Y, et al. Beneficial effects of biomimetic nano-sized hydroxyapatite/antibiotic gentamicin enriched chitosan–glycerophosphate hydrogel on the performance of injectable polymethylmethacrylate. RSC Adv. 2015;5(110):91082–92.

    Article  CAS  Google Scholar 

  22. Shi M, et al. Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials. 2010;31(14):4146–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Spicer PP, et al. Evaluation of antibiotic releasing porous polymethylmethacrylate space maintainers in an infected composite tissue defect model. Acta Biomater. 2013;9(11):8832–9.

    Article  CAS  PubMed  Google Scholar 

  24. Ayre WN, et al. A novel liposomal drug delivery system for PMMA bone cements. J Biomed Mater Res B Appl Biomater. 2016;104(8):1510–24.

    Article  CAS  PubMed  Google Scholar 

  25. Abosala A, Ali M. The Use of Calcium Sulphate beads in Periprosthetic Joint Infection, a systematic review. J Bone Jt Infect. 2020;5(1):43–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kallala R, et al. Use of Stimulan absorbable calcium sulphate beads in revision lower limb arthroplasty: Safety profile and complication rates. Bone Joint Res. 2018;7(10):570–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Shirtliff ME, Calhoun JH, Mader JT. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin Orthop Relat Res, 2002(401): p. 239–47.

  28. Sullivan SJ, Topoleski LD. Influence of initial component temperature on the apparent viscosity and handling characteristics of acrylic (PMMA) bone cement. J Biomed Mater Res B Appl Biomater. 2007;81(1):224–30.

    Article  PubMed  Google Scholar 

  29. Parry MC, Duncan CP, The challenge of methicillin resistant staphylococcal infection after total hip replacement: overlooked or overstated? Bone Joint J, 2014. 96-b(11 Supple A): p. 60 – 5.

  30. Pimentel de Araujo, F, et al. Staphylococcus aureus clones causing osteomyelitis: a literature review (2000–2020). J Glob Antimicrob Resist. 2021;26:29–36.

    Article  Google Scholar 

  31. Paz E, et al. Evaluation of Elution and Mechanical Properties of High-Dose Antibiotic-Loaded Bone Cement: Comparative “In Vitro” Study of the Influence of Vancomycin and Cefazolin. J Arthroplasty. 2015;30(8):1423–9.

    Article  PubMed  Google Scholar 

  32. Borshchevskaya LN, et al. Spectrophotometric determination of lactic acid. J Anal Chem. 2016;71(8):755–8.

    Article  CAS  Google Scholar 

  33. Moldovan Z, et al. A Derivative Spectrometric Method for Hydroquinone Determination in the Presence of Kojic Acid, Glycolic Acid, and Ascorbic Acid. J Spectrosc. 2017;2017:6929520.

    Article  Google Scholar 

  34. Al-Qattan MM. Vicryl Rapide versus Vicryl suture in skin closure of the hand in children: a randomized prospective study. J Hand Surg Br. 2005;30(1):90–1.

    Article  CAS  PubMed  Google Scholar 

  35. Matsumine H, Takeuchi M. Usefulness of Irradiated Polyglactin 910 (Vicryl Rapide) for Skin Suturing during Surgery for Lateral Ray Polydactyly of the Toes in Children. Plast Reconstr Surg Glob Open. 2013;1(6):e42.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Carli AV, et al. Vancomycin-Loaded Polymethylmethacrylate Spacers Fail to Eradicate Periprosthetic Joint Infection in a Clinically Representative Mouse Model. J Bone Joint Surg Am. 2018;100(11):e76.

    Article  PubMed  Google Scholar 

  37. Dagneaux L, et al. Renal Toxicity Associated With Resection and Spacer Insertion for Chronic Hip PJI. J Arthroplasty. 2021;36(9):3289–93.

    Article  PubMed  Google Scholar 

  38. Dagneaux L, et al. Acute Kidney Injury When Treating Periprosthetic Joint Infections After Total Knee Arthroplasties with Antibiotic-Loaded Spacers: Incidence, Risks, and Outcomes. J Bone Joint Surg Am. 2021;103(9):754–60.

    Article  PubMed  Google Scholar 

  39. Chan JJ, et al., Antibiotic-Loaded Bone Cement in Primary Total Knee Arthroplasty: Utilization Patterns and Impact on Complications Using a National Database. J Arthroplasty, 2019. 34(7s): p. S188-S194.e1.

  40. Giavaresi G, et al. New PMMA-based composites for preparing spacer devices in prosthetic infections. J Mater Sci Mater Med. 2012;23(5):1247–57.

    Article  CAS  PubMed  Google Scholar 

  41. Lu CY, et al. Modified Cyclodextrin Microparticles to Improve PMMA Drug Delivery Without Mechanical Loss. Macromol Biosci. 2021;21(7):e2000328.

    Article  PubMed  Google Scholar 

  42. García-García J, et al., Modification of the Polymer of a Bone Cement with Biodegradable Microspheres of PLGA and Loading with Daptomycin and Vancomycin Improve the Response to Bone Tissue Infection. Polymers (Basel), 2022. 14(5).

  43. Zupančič Š, et al. Long-Term Sustained Ciprofloxacin Release from PMMA and Hydrophilic Polymer Blended Nanofibers. Mol Pharm. 2016;13(1):295–305.

    Article  PubMed  Google Scholar 

  44. Salim SA, et al. Mercaptopurine-Loaded Sandwiched Tri-Layered Composed of Electrospun Polycaprolactone/Poly(Methyl Methacrylate) Nanofibrous Scaffolds as Anticancer Carrier with Antimicrobial and Antibiotic Features: Sandwich Configuration Nanofibers, Release Study and in vitro Bioevaluation Tests. Int J Nanomedicine. 2021;16:6937–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Shen SC, et al. Nanostructured material formulated acrylic bone cements with enhanced drug release. Mater Sci Eng C Mater Biol Appl. 2016;58:233–41.

    Article  CAS  PubMed  Google Scholar 

  46. Letchmanan K, et al. Mechanical properties and antibiotic release characteristics of poly(methyl methacrylate)-based bone cement formulated with mesoporous silica nanoparticles. J Mech Behav Biomed Mater. 2017;72:163–70.

    Article  CAS  PubMed  Google Scholar 

  47. Al Thaher Y, Perni S, Prokopovich P. Nano-carrier based drug delivery systems for sustained antimicrobial agent release from orthopaedic cementous material. Adv Colloid Interface Sci. 2017;249:234–47.

    Article  CAS  PubMed  Google Scholar 

  48. Liang ZC, et al. Carboxylic acid-functionalized polycarbonates as bone cement additives for enhanced and sustained release of antibiotics. J Control Release. 2021;329:871–81.

    Article  CAS  PubMed  Google Scholar 

  49. Shen SC, et al. Antibiotic elution and mechanical property of TiO(2) nanotubes functionalized PMMA-based bone cements. J Mech Behav Biomed Mater. 2019;91:91–8.

    Article  CAS  PubMed  Google Scholar 

  50. Abdulrazzaq Naji S, et al. Effects of incorporation of 2.5 and 5 wt% TiO(2) nanotubes on fracture toughness, flexural strength, and microhardness of denture base poly methyl methacrylate (PMMA). J Adv Prosthodont. 2018;10(2):113–21.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Alrahlah A, et al., Titanium Oxide (TiO2)/Polymethylmethacrylate (PMMA) Denture Base Nanocomposites: Mechanical, Viscoelastic and Antibacterial Behavior. Materials (Basel), 2018. 11(7).

  52. Al Thaher Y, et al., Antimicrobial PMMA Bone Cement Containing Long Releasing Multi-Walled Carbon Nanotubes. Nanomaterials (Basel), 2022. 12(8).

  53. Wei W, et al. Clay Nanotube/Poly(methyl methacrylate) Bone Cement Composites with Sustained Antibiotic Release. Macromol Mater Eng. 2012;297(7):645–53.

    Article  CAS  Google Scholar 

  54. Cyphert EL, et al. An Additive to PMMA Bone Cement Enables Postimplantation Drug Refilling, Broadens Range of Compatible Antibiotics, and Prolongs Antimicrobial Therapy. Adv Healthc Mater. 2018;7(21):e1800812.

    Article  PubMed  Google Scholar 

  55. Cyphert EL, et al., Poly(methyl methacrylate) Bone Cement Composite Can Be Refilled with Antibiotics after Implantation in Femur or Soft Tissue. J Funct Biomater, 2021. 12(1).

  56. Hsu PY, et al. Manipulation of the degradation behavior of calcium sulfate by the addition of bioglass. Prog Biomater. 2019;8(2):115–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Chen QZ, Thompson ID, Boccaccini AR, 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials, 2006. 27(11): p. 2414-25.

  58. Zhang X, et al. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials. 2010;31(22):5865–74.

    Article  CAS  PubMed  Google Scholar 

  59. Zheng Y, et al. In vitro bioactivity evaluation of $$\upalpha $$-calcium sulphate hemihydrate and bioactive glass composites for their potential use in bone regeneration. Bull Mater Sci. 2018;41(2):59.

    Article  Google Scholar 

  60. Funk GA, et al. Antibiotic Elution and Mechanical Strength of PMMA Bone Cement Loaded With Borate Bioactive Glass. J Bone Jt Infect. 2018;3(4):187–96.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Funk GA, et al. Elution of rifampin and vancomycin from a weight-bearing silorane-based bone cement. Bone Joint Res. 2021;10(4):277–84.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


We thank the staff of the Third Core Lab, Department of Medical Research, National Taiwan University Hospital, for technical assistance. We thank Ms. Su-Jen Ji of Ministry of Science and Technology (National Taiwan University) for the assistance in SEM/EDS experiments. We thank Dr. Jin-Town Wang for providing MRSA.


This research was financially supported by National Taiwan University Hospital (NTUH) with grant No. 111-M0010.

Author information

Authors and Affiliations



All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Tzu Hao Tseng, Chien-Lin Chen, Jyh-Horng Wang and Tai-Horng Young. The first draft of the manuscript was written by Tzu-Hao Tseng and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jyh-Horng Wang or Tai-Horng Young.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tseng, TH., Chang, CH., Chen, CL. et al. A simple method to improve the antibiotic elution profiles from polymethylmethacrylate bone cement spacers by using rapid absorbable sutures. BMC Musculoskelet Disord 23, 916 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • PMMA
  • Cement
  • Release
  • Infection
  • Antibiotics